Mark Kimbrough | VP, IR |
Samuel Hazen | CEO & Director |
William Rutherford | EVP & CFO |
Jonathan Perlin | President, Clinical Services Group & Chief Medical Officer |
Philip Chickering | Deutsche Bank |
Frank Morgan | RBC Capital Markets |
Kevin Fischbeck | Bank of America Merrill Lynch |
A.J. Rice | Crédit Suisse |
Scott Fidel | Stephens Inc. |
Ralph Giacobbe | Citigroup |
Benjamin Mayo | UBS Investment Bank |
Stephen Tanal | Goldman Sachs Group |
Andrew Mok | Barclays Bank |
Joshua Raskin | Nephron Research |
Michael Newshel | Evercore ISI |
Justin Lake | Wolfe Research |
Sarah James | Piper Sandler & Co. |
Gary Taylor | JPMorgan Chase & Co. |
Brian Tanquilut | Jefferies |
Peter Costa | Wells Fargo Securities |
Matthew Gillmor | Robert W. Baird & Co. |
Matthew Borsch | BMO Capital Markets |
Welcome to the HCA Healthcare Fourth Quarter 2019 Earnings Conference Call. Today's call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations, Mark Kimbrough. Please go ahead, sir.
Kevin, thank you so much.